Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1995760094;60095;60096 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
N2AB1831655171;55172;55173 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
N2A1738952390;52391;52392 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
N2B1089232899;32900;32901 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
Novex-11101733274;33275;33276 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
Novex-21108433475;33476;33477 chr2:178592035;178592034;178592033chr2:179456762;179456761;179456760
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAT
  • RefSeq wild type template codon: ATA
  • Domain: Fn3-32
  • Domain position: 81
  • Structural Position: 114
  • Q(SASA): 0.6324
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/F None None 0.046 N 0.309 0.148 0.309530620856 gnomAD-4.0.0 5.476E-06 None None None None I None 0 0 None 0 0 None 0 0 7.19718E-06 0 0
Y/H rs772991524 0.351 0.997 N 0.595 0.383 0.319686207203 gnomAD-2.1.1 1.21E-05 None None None None I None 0 0 None 0 0 None 9.81E-05 None 0 0 0
Y/H rs772991524 0.351 0.997 N 0.595 0.383 0.319686207203 gnomAD-3.1.2 6.57E-06 None None None None I None 0 0 0 0 0 None 0 0 0 2.07211E-04 0
Y/H rs772991524 0.351 0.997 N 0.595 0.383 0.319686207203 gnomAD-4.0.0 1.53868E-05 None None None None I None 0 0 None 0 0 None 0 0 2.39453E-06 1.47469E-04 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.9156 likely_pathogenic 0.8864 pathogenic -0.685 Destabilizing 0.976 D 0.623 neutral None None None None I
Y/C 0.4536 ambiguous 0.4042 ambiguous 0.136 Stabilizing 0.999 D 0.735 prob.delet. N 0.463935028 None None I
Y/D 0.8897 likely_pathogenic 0.8761 pathogenic 0.827 Stabilizing 0.997 D 0.701 prob.neutral N 0.517958727 None None I
Y/E 0.9532 likely_pathogenic 0.9468 pathogenic 0.802 Stabilizing 0.998 D 0.697 prob.neutral None None None None I
Y/F 0.0985 likely_benign 0.1039 benign -0.388 Destabilizing 0.046 N 0.309 neutral N 0.402886569 None None I
Y/G 0.9126 likely_pathogenic 0.8863 pathogenic -0.869 Destabilizing 0.993 D 0.679 prob.neutral None None None None I
Y/H 0.5117 ambiguous 0.4792 ambiguous 0.224 Stabilizing 0.997 D 0.595 neutral N 0.494313863 None None I
Y/I 0.7617 likely_pathogenic 0.7513 pathogenic -0.229 Destabilizing 0.973 D 0.623 neutral None None None None I
Y/K 0.9595 likely_pathogenic 0.9454 pathogenic 0.218 Stabilizing 0.998 D 0.694 prob.neutral None None None None I
Y/L 0.7874 likely_pathogenic 0.7632 pathogenic -0.229 Destabilizing 0.91 D 0.623 neutral None None None None I
Y/M 0.8545 likely_pathogenic 0.8381 pathogenic -0.066 Destabilizing 0.998 D 0.637 neutral None None None None I
Y/N 0.6586 likely_pathogenic 0.6394 pathogenic 0.034 Stabilizing 0.997 D 0.703 prob.neutral N 0.476381463 None None I
Y/P 0.9932 likely_pathogenic 0.9914 pathogenic -0.361 Destabilizing 0.998 D 0.714 prob.delet. None None None None I
Y/Q 0.9201 likely_pathogenic 0.9007 pathogenic 0.055 Stabilizing 0.998 D 0.655 neutral None None None None I
Y/R 0.9146 likely_pathogenic 0.8902 pathogenic 0.509 Stabilizing 0.998 D 0.704 prob.neutral None None None None I
Y/S 0.8385 likely_pathogenic 0.7976 pathogenic -0.386 Destabilizing 0.991 D 0.676 prob.neutral N 0.479864485 None None I
Y/T 0.9328 likely_pathogenic 0.9147 pathogenic -0.32 Destabilizing 0.993 D 0.683 prob.neutral None None None None I
Y/V 0.704 likely_pathogenic 0.6645 pathogenic -0.361 Destabilizing 0.953 D 0.657 neutral None None None None I
Y/W 0.5517 ambiguous 0.5467 ambiguous -0.512 Destabilizing 0.999 D 0.589 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.